Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID ...
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
A research team at the University of Konstanz, led by toxicologist Ivano Amelio, has demonstrated how differently individual mutations of the tumor suppressor p53 affect pancreatic carcinomas. When ...
TP53 mutations are crucial in cancer development and treatment response, influenced by genetic and environmental factors. In CLL and AML, TP53 serves as a significant prognostic marker, affecting ...
An open-label phase 1/2 study of DCC-3009 monotherapy in patients with advanced gastrointestinal stromal tumor. PYNNACLE Phase 1/2 basket study (NCT04585750). · Prior standard therapy or ineligible ...
Microbes in the gut can change the effects of genetic mutations (LJNovaScotia/Pixabay/) Health blogs and diet websites often tout antioxidants as a cure-all for gut health. But the story of the gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback